{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:25:48Z","timestamp":1773847548001,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Managing individuals with both HIV infection and a history of solid organ transplantation presents unique challenges due to interactions between antiretroviral therapy and immunosuppressive regimens. Long-acting injectable therapies may offer advantages in reducing drug interactions and improving adherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study assessed the virological efficacy and safety of long-acting injectable therapy with a combination of 2 antiviral agents in 5 patients with stable HIV infection who had undergone kidney or liver transplantation. Patients were followed for up to 74 weeks after initiating therapy. Virological response, immunological parameters, renal and hepatic function, and immunosuppressive drug levels were monitored.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>All patients maintained undetectable viral loads throughout the study period, with no virological failure or drug-resistance development. CD4+ T-cell counts remained stable, and no clinically significant changes in renal or hepatic function were observed. Immunosuppressive drug levels remained within the therapeutic range without requiring dose adjustments. No patient experienced severe adverse effects or injection-site complications, and adherence was high throughout the study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Long-acting injectable therapy was effective and well tolerated in individuals with stable HIV infection following solid organ transplantation. The findings suggest that this approach may be a viable treatment option, reducing drug interactions while maintaining virological suppression. Further research with larger cohorts is needed to confirm these findings and establish guidelines for implementation in transplant recipients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf470","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:22:11Z","timestamp":1755501731000},"source":"Crossref","is-referenced-by-count":1,"title":["Long-Acting Cabotegravir and Rilpivirine in Patients With HIV With Solid Organ Transplantation: A Case Series"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4407-3864","authenticated-orcid":false,"given":"Ana","family":"Moreno","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]},{"name":"CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6441-4141","authenticated-orcid":false,"given":"Ruben","family":"Fernandez-Ibanez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Del Campo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J","family":"Perez-Elias","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]},{"name":"CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-8591","authenticated-orcid":false,"given":"Jose L","family":"Casado","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]},{"name":"CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Garcia","sequence":"additional","affiliation":[{"name":"Gastroenterology Department (Liver Transplant Unit), University Hospital Ramon y Cajal , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Velez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, University Hospital Ramon y Cajal , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-6011","authenticated-orcid":false,"given":"Maria J","family":"Vivancos","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]},{"name":"CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2843-1094","authenticated-orcid":false,"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Ram\u00f3n y Cajal, IRYCIS , Madrid ,","place":["Spain"]},{"name":"CIBERINFEC, Instituto de Salud Carlos III , Madrid ,","place":["Spain"]},{"name":"Gastroenterology Department (Liver Transplant Unit), University Hospital Ramon y Cajal , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2025082211414349800_ofaf470-B1","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.crphar.2021.100044","article-title":"Pharmacokinetic drug interactions of integrase strand transfer inhibitors","volume":"2","author":"Lu","year":"2021","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"2025082211414349800_ofaf470-B2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11904-013-0170-z","article-title":"Solid organ transplants in HIV-infected patients","volume":"10","author":"Harbell","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025082211414349800_ofaf470-B3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/lt.23522","article-title":"Renal dysfunction in liver transplant recipients: evaluation of the critical issues","volume":"18","author":"Weber","year":"2012","journal-title":"Liver Transpl"},{"key":"2025082211414349800_ofaf470-B4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12981-019-0253-z","article-title":"Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis","volume":"16","author":"Zheng","year":"2019","journal-title":"AIDS Res Ther"},{"key":"2025082211414349800_ofaf470-B5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-6143.2005.00748.x","article-title":"Pharmacokinetic principles of immunosuppressive drugs","volume":"5","author":"Srinivas","year":"2005","journal-title":"Am J Transplant"},{"key":"2025082211414349800_ofaf470-B6","author":"U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents"},{"key":"2025082211414349800_ofaf470-B7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/1120009X.2021.1940436","article-title":"Bictegravir\/emtricitabine\/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants","volume":"34","author":"Lagoutte-Renosi","year":"2022","journal-title":"J Chemother"},{"key":"2025082211414349800_ofaf470-B8","author":"National Institutes of Health (NIH)"},{"key":"2025082211414349800_ofaf470-B9","doi-asserted-by":"crossref","first-page":"e13499","DOI":"10.1111\/ctr.13499","article-title":"American Society of Transplantation Infectious Diseases Community of Practice. Solid organ transplantation in the HIV-infected patient: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Blumberg","year":"2019","journal-title":"Clin Transplant"},{"key":"2025082211414349800_ofaf470-B10","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S2352-3018(23)00300-4","article-title":"Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017\/MOCHA): a phase 1\/2, multicentre, open-label, non-comparative, dose-finding study","volume":"11","author":"Gaur","year":"2024","journal-title":"Lancet HIV"},{"key":"2025082211414349800_ofaf470-B11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/QAD.0000000000003567","article-title":"Use of long-acting cabotegravir\u200a+\u200arilpivirine during hemodialysis and solid organ transplantation","volume":"37","author":"Rezzonico","year":"2023","journal-title":"AIDS"},{"key":"2025082211414349800_ofaf470-B12","author":"Drug Interaction Checker"},{"key":"2025082211414349800_ofaf470-B13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/17425255.2024.2448970","article-title":"Considerations for drug\u2013drug interactions between long-acting antiretrovirals and immunosuppressants for solid organ transplantation","volume":"21","author":"Coppinger","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 2","key":"2025082211414349800_ofaf470-B14","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002950","article-title":"Pharmacokinetic interactions of modern antiretroviral therapy","volume":"35","author":"Sinxadi","year":"2021","journal-title":"AIDS"},{"key":"2025082211414349800_ofaf470-B15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/FTD.0000000000000205","article-title":"Impact of laboratory practices on interlaboratory variability in therapeutic drug monitoring of immunosuppressive drugs","volume":"37","author":"Christians","year":"2015","journal-title":"Ther Drug Monit"},{"key":"2025082211414349800_ofaf470-B16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40121-021-00430-w","article-title":"Tacrolimus, sirolimus and everolimus doses in HIV-infected solid-organ recipients, requiring a cobicistat-based antiretroviral regimen: report of three cases and review","volume":"10","author":"Diaz","year":"2021","journal-title":"Infect Dis Ther"},{"key":"2025082211414349800_ofaf470-B17","doi-asserted-by":"crossref","first-page":"ofab439","DOI":"10.1093\/ofid\/ofab439","article-title":"Efficacy, safety, and durability of long-acting cabotegravir and rilpivirine in adults with human immunodeficiency virus type 1 infection: 5-year results from the LATTE-2 study","volume":"8","author":"Smith","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025082211414349800_ofaf470-B18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/20786204.2006.10873433","article-title":"Adherence to HIV antiretroviral therapy: part I: a review of factors that influence adherence: open forum","volume":"48","author":"Heyer","year":"2006","journal-title":"S Afr Fam Pract (2004)"},{"key":"2025082211414349800_ofaf470-B19","first-page":"179","article-title":"Evaluating cabotegravir\/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential","volume":"11","author":"Fernandez","year":"2019","journal-title":"HIV AIDS (Auckl)"},{"key":"2025082211414349800_ofaf470-B20","doi-asserted-by":"crossref","first-page":"ofae282","DOI":"10.1093\/ofid\/ofae282","article-title":"Cabotegravir+ rilpivirine long-acting: overview of injection guidance, injection site reactions, and best practices for intramuscular injection administration","volume":"11","author":"Teichner","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025082211414349800_ofaf470-B21","doi-asserted-by":"crossref","first-page":"e46767","DOI":"10.2196\/46767","article-title":"Safety and efficacy of long-acting injectable agents for HIV-1: systematic review and meta-analysis","volume":"9","author":"Wang","year":"2023","journal-title":"JMIR Public Health Surveill"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf470\/64072303\/ofaf470.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/8\/ofaf470\/64072303\/ofaf470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/8\/ofaf470\/64072303\/ofaf470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:41:52Z","timestamp":1755877312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf470\/8237101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf470","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,31]]},"article-number":"ofaf470"}}